A Descriptive Study on Patients With Bipolar Disorder in Rwanda

• Conditions: Bipolar Disorder; Mental Disorder

• Registration Number: NCT04674059
• Lead Sponsor: University of Aarhus

Brief Summary

The aim is to provide a comprehensive assessment regarding the service provision and the accessibility to intensive mental health care in Rwanda

Detailed Description

The aim is to provide a comprehensive assessment regarding the service provision and the accessibility to intensive mental health care in Rwanda for patients with bipolar disorder.

Knowing about the barriers to treatment, risk and protective factors as well as the current treatment offered for patients with bipolar disorder is essential for the development of therapeutic approaches and improvement in access to care. Up to now, no data on characteristics of patients with bipolar disorder in Rwanda and related risk and protective factors is available. For this purpose, all outpatients with bipolar disorder in Rwanda age \> 18 years, will over a 1-year period be invited to participate in a survey on their experience living with bipolar disorder in Rwanda. Moreover, patients and relatives will be invited for in-depth interviews to explore their perceptions and experiences with the mental health system. Health care providers will meet for focus discussions on to assess the experience, knowledge and practice of caregiving for individuals with bipolar disorder.

Basic Information
|
Recruitment & Eligibility
|
Study & Design

Study Timeline

• Status Verified: 2020-12
• Study First Submitted: 2020-12-04
• Study First Submitted QC: 2020-12-15
• Last Update Submitted: 2020-12-15
• Study First Posted: 2020-12-17
• Last Update Posted: 2020-12-17
• Study Start: 2021-01-01
• Primary Completion: 2021-12-31
• Study Completion: 2021-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

• A diagnosis of Bipolar Disorder type I or II that meets DSM-V diagnostic criteria
• Age ≥ 18 years

Read More

Exclusion Criteria

• None

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Medical Adherence	1 year	Medication Adherence Rating Scale (MARS) will be used to assess beliefs and barriers to medication adherence. Total scores on the MARS may range between 0 and 10, with a higher score indicating better medication adherence.
Diagnoses	1 year	Psychiatric diagnoses including both primary diagnosis, secondary diagnosis and somatic comorbidity.
Number of previous crises	1 year	Numerical value of the previous crises defined as an episode of depression or mania or hypomania.
The referral pathways	1 year	Who initiated the first contact, who did you seek for help, what kind of help was provided, percent of patients who came in contact with traditional leaders.
Degree of internal stigma	1 year	Internalized Stigma of Mental Illness Inventory - 9-item Version (ISMI-9) will be used to assess self-stigma. The resulting score should range from 1 to 4. A score ranging between 1.00-2.50: does not report high internalized stigma vs. a score ranging between 2.51-4.00: indicating high internalized stigma.
Number of previous psychiatric hospitalisations	1 year	Numerical value of the previous psychiatric hospitalisations.
Types of medical treatment provided	1 year	What type of medical treatment is provided, including brand name, administration and dosage.
Diagnostic delay	1 year	Age of individual at onset of symptoms and age when diagnosed with bipolar disorder.